AstraZeneca PLC

AstraZeneca: CHMP Recommends Lynparza And Imfinzi Combination For EU Approval In Endometrial Cancer

01 июл 2024 03:09:21 Источник NASDAQ US Markets

Pharma Stock Roundup: FDA's CRL to MRK & ABBV, Phase III Study Failures for NVO, AZN

28 июн 2024 10:33:02 Источник NASDAQ Stocks

AstraZeneca: Imfinzi Trial Fails To Meet Endpoint In Early-stage Non-small Cell Lung Cancer

25 июн 2024 03:08:02 Источник NASDAQ US Markets

AstraZeneca: Phase III Truqap Trial Plus Chemotherapy Fails To Meet Primary Goals In Breast Cancer

18 июн 2024 03:15:21 Источник NASDAQ US Markets

AstraZeneca's Calquence Combo Cuts Progression Risk By 27% In Mantle Cell Lymphoma Trial

16 июн 2024 12:33:03 Источник NASDAQ US Markets

FDA Approves AstraZeneca's Farxiga For Pediatric Use In Type-2 Diabetes

12 июн 2024 21:53:19 Источник NASDAQ US Markets

NetDania - New 12 months High: AstraZeneca PLC

10 июн 2024 03:21:31 Источник NetDania Notify

1 Biopharma Stock Setting the New Standard in Cancer Care Drugs

07 июн 2024 12:13:02 Источник NASDAQ Stocks

Summit Therapeutics, AstraZeneca And More From The Year’s Biggest Cancer Conference

05 июн 2024 19:29:29 Источник Forbes - World

AstraZeneca Completes Acquisition Of Fusion Pharma

05 июн 2024 03:08:45 Источник NASDAQ US Markets

CHMP Recommends Approval Of AstraZeneca's Tagrisso Combo For EGFR-Mutated Advanced Lung Cancer

03 июн 2024 03:15:45 Источник NASDAQ US Markets

Amgen's Bkemv Approved As First Interchangeable Biosimilar To Soliris

30 май 2024 05:59:20 Источник NASDAQ US Markets

AstraZeneca Just Massively One-Upped Pfizer. Here's What It Means for the Stock

29 май 2024 10:20:48 Источник NASDAQ US Markets

AstraZeneca Plans to Rake in $80 Billion by 2030. Should You Buy the Stock?

29 май 2024 08:32:19 Источник NASDAQ US Markets

AZN:Datopotamab Deruxtecan Shows Favorable Survival Results, Falls Short Of Statistical Significance

27 май 2024 02:59:14 Источник NASDAQ US Markets

Pharma Stock Roundup: AZN's 2030 Sales Target, PFE's New Cost Cut Plan & More

24 май 2024 10:30:58 Источник NASDAQ Stocks

AstraZeneca Targets $80 Bln Revenue By 2030, Plans To Launch 20 New Medicines

21 май 2024 03:02:29 Источник NASDAQ US Markets

AstraZeneca To Build $1.5 Bln Manufacturing Facility In Singapore For Antibody Drug Conjugates

20 май 2024 02:42:36 Источник NASDAQ US Markets

AstraZeneca: New Data Shows Tezspire's Role In Future COPD Treatment

19 май 2024 22:05:22 Источник NASDAQ US Markets

AZN:Phase III Trial Of Sipavibart Met Main Goal In Preventing COVID-19 In Immunocompromised Patients

16 май 2024 03:51:29 Источник NASDAQ US Markets